Bremelanotide
8 research papers indexed
FDA Vyleesi REMS Determination NDA 210557
0
FDA NDA 210557
·2019RegulatoryHumanHSDD in premenopausal womenSourceFDA
Clayton 2022 — Integrated Safety Profile Bremelanotide
0
Journal of Womens Health
·2022ReviewHumanSexual dysfunction (female HSDD)SourceSafety
Vyleesi FDA Label 2019
0
FDA Package Insert
·2019RegulatoryHumanHSDDSourceFDA
Simon 2019 — RECONNECT Open-Label Extension
0
J Sex Med
·2019ExtensionHumanFemale HSDDSourceExtension
Diamond 2005 — Intranasal PT-141 + Sildenafil in ED
0
Urology
·2005RCTHumanMale EDSourceOff Label Male
Clayton 2017 — Ambulatory BP Monitoring of Bremelanotide
0
Blood Pressure Monitoring
·2017RCTHumanFemale sexual dysfunctionSourceCardiovascular
Safarinejad 2008 — Bremelanotide Salvage ED
0
Urology
·2008ClinicalHumanErectile dysfunction in sildenafil non-respondersSourceClinical
Kingsberg 2019 — RECONNECT Phase 3 Trials
0
Obstet Gynecol
·2019RCTHumanFemale HSDDSourceRCT